[{"arm_notes": "", "treatment_id": null, "treatment_name": "The study will be based at several COVID-19 treatment centres namely the National Institute of Infectious Diseases (NIID) commonly known as Infectious Diseases hospital-Angoda; This is a blinded study. Neither participants; nor investigators; will be aware of treatment assignments prior to the conclusion of the study.Computer-generated random numbers will be generated in blocks of 10 for randomization. Either \u201civermectin\u201d tablets or placebo tablets will be packed into identical packages numbered from 1 to 400 according to the list of computer-generated random numbers.Interventional arm will receive Ivermectin 24 mg daily for 5 days and standard care given to any other patient admitted to hospital (circular dated 02.12.20: Health.gov.lk. 2021. home. [online] Available at: <http://health.gov.lk/>) [duration]Control arm will receive the same strength and weight look alike placebo tablets and standard care given to any other patient admitted to hospital (circular dated 02.12.20: Health.gov.lk. 2021. home. [online] Available at: <http://health.gov.lk/>) for five days.The control arm will receive a placebo as 24mg daily for 05 days. Ingredients in the placebo include Microcrystalline Cellulose; Pregelatinised Starch;Sodium Starch; Anhydrous Citric acid; Butylated Hydroxyanisole; Pigment Blend Yellow (PB 3071); Colloid Anhydrous Silica and Magnesium Stearate", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 693, "treatment_name": "Ivermectin", "treatment_type": "Antiparasitics", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]